Top Markets
Coin of the day
GBS Inc. GBS Inc.

GBS Inc.

GBS
Kedudukan dalam Saham #33721
Operating across North America and the Asia-Pacific region, GBS Inc.... Operating across North America and the Asia-Pacific region, GBS Inc. specializes in biosensor diagnostic technology. Its key product is the Saliva Glucose Biosensor, an innovative organic thin-film transistor designed for diabetes management that quantifies glucose levels directly from saliva. The company is also actively advancing a SARS-CoV-2 Biosensor, intended as a supplementary diagnostic tool to existing RNA virus detection tests, and is constructing a broad biosensor platform covering diagnostic modalities such as biochemistry, immunology, tumor markers, hormones, and nucleic acids. GBS Inc. maintains a research agreement with the Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic solutions. Founded in 2016 and headquartered in New York, New York, the company adopted its current name, GBS Inc., in September 2019, having previously operated as Glucose Biosensor Systems (Greater China) Holdings, Inc. It operates as a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Harga Saham
$0.4732
Disegerakkan terakhir: 2022-10-26
Modal Pasaran
$7.05M
Perubahan (1 hari)
-0.03%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan GBS Inc. (GBS)

Kategori

Sejarah pecahan saham untuk GBS Inc. (GBS)
Saham GBS Inc. (simbol: GBS) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 17, 2026.
Satu saham GBS yang dibeli sebelum Aug 17, 2026 kini bersamaan dengan 0 saham GBS.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
9 x285
US
9 x162
US
7 x127
IE
2 x4
US
3 x12
US